BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ralph SJ, Espinet AJ. Increased All-Cause Mortality by Antipsychotic Drugs: Updated Review and Meta-Analysis in Dementia and General Mental Health Care. J Alzheimers Dis Rep 2018;2:1-26. [PMID: 30480245 DOI: 10.3233/ADR-170042] [Cited by in Crossref: 37] [Cited by in F6Publishing: 22] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Mendez MF. Managing the Behavioral and Psychological Symptoms of Dementia. Curr Treat Options Neurol. [DOI: 10.1007/s11940-022-00715-6] [Reference Citation Analysis]
2 Zhang C, Wang L, Xu Y, Huang Y, Huang J, Zhu J, Wang W, Li W, Sun A, Li X, Zhang H, Li J. Discovery of novel dual RAGE/SERT inhibitors for the potential treatment of the comorbidity of Alzheimer's disease and depression. European Journal of Medicinal Chemistry 2022;236:114347. [DOI: 10.1016/j.ejmech.2022.114347] [Reference Citation Analysis]
3 Bargagli AM, Cascini S, Agabiti N, Kirchmayer U, Marino C, Davoli M. Determinants Of Antipsychotic Drugs Prescription Among Community-Living Older Adults With Dementia: A Population-Based Study Using Health Information Systems In The Lazio Region, Italy. Clin Interv Aging 2019;14:2071-83. [PMID: 31819389 DOI: 10.2147/CIA.S218641] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
4 Dimitriou T, Papatriantafyllou J, Konsta A, Kazis D, Athanasiadis L, Ioannidis P, Koutsouraki E, Tegos T, Tsolaki M. Non-Pharmacological Interventions for Wandering/Aberrant Motor Behaviour in Patients with Dementia. Brain Sciences 2022;12:130. [DOI: 10.3390/brainsci12020130] [Reference Citation Analysis]
5 Kelleher JE, Weedle P, Donovan MD. The Prevalence of and Documented Indications for Antipsychotic Prescribing in Irish Nursing Homes. Pharmacy (Basel) 2021;9:160. [PMID: 34698248 DOI: 10.3390/pharmacy9040160] [Reference Citation Analysis]
6 Siddappaji KK, Gopal S. Molecular mechanisms in Alzheimer's disease and the impact of physical exercise with advancements in therapeutic approaches. AIMS Neurosci 2021;8:357-89. [PMID: 34183987 DOI: 10.3934/Neuroscience.2021020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 May M, Beauchemin M, Vary C, Barlow D, Houseknecht KL. The antipsychotic medication, risperidone, causes global immunosuppression in healthy mice. PLoS One 2019;14:e0218937. [PMID: 31242264 DOI: 10.1371/journal.pone.0218937] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
8 Li X, Li J, Huang Y, Gong Q, Fu Y, Xu Y, Huang J, You H, Zhang D, Zhang D, Mao F, Zhu J, Wang H, Zhang H, Li J. The novel therapeutic strategy of vilazodone-donepezil chimeras as potent triple-target ligands for the potential treatment of Alzheimer's disease with comorbid depression. Eur J Med Chem 2021;229:114045. [PMID: 34922191 DOI: 10.1016/j.ejmech.2021.114045] [Reference Citation Analysis]
9 Kwon CY, Lee B. Herbal Medicine for Behavioral and Psychological Symptoms of Dementia: A Systematic Review and Meta-Analysis. Front Pharmacol 2021;12:713287. [PMID: 34385925 DOI: 10.3389/fphar.2021.713287] [Reference Citation Analysis]
10 Wang LY, Pei J, Zhan YJ, Cai YW. Overview of Meta-Analyses of Five Non-pharmacological Interventions for Alzheimer's Disease. Front Aging Neurosci 2020;12:594432. [PMID: 33324194 DOI: 10.3389/fnagi.2020.594432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Waykar V, Wourms K, Bhat G, Farrow A. Antipsychotic use in dementia – local quality improvement initiative. Prog Neurol Psychiatry 2021;25:26-30. [DOI: 10.1002/pnp.695] [Reference Citation Analysis]
12 Calsolaro V, Antognoli R, Okoye C, Monzani F. The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer's Disease. Front Pharmacol 2019;10:1465. [PMID: 31920655 DOI: 10.3389/fphar.2019.01465] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
13 Halavonich L, Robert S, McGraw D, Weeda E, Mullinax K, Bass B. Management of delirium at an academic medical center: Plans for antipsychotic prescribing upon discharge. Ment Health Clin 2020;10:25-9. [PMID: 31942275 DOI: 10.9740/mhc.2020.01.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Lee JH, Lee CJ, Park J, Lee SJ, Choi SH. The Neuroinflammasome in Alzheimer's Disease and Cerebral Stroke. Dement Geriatr Cogn Dis Extra 2021;11:159-67. [PMID: 34249072 DOI: 10.1159/000516074] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Ruangritchankul S, Peel NM, Hanjani LS, Gray LC. Drug related problems in older adults living with dementia. PLoS One 2020;15:e0236830. [PMID: 32735592 DOI: 10.1371/journal.pone.0236830] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Calsolaro V, Femminella GD, Rogani S, Esposito S, Franchi R, Okoye C, Rengo G, Monzani F. Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics. Pharmaceuticals (Basel) 2021;14:246. [PMID: 33803277 DOI: 10.3390/ph14030246] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Neef J, Palacios DS. Progress in mechanistically novel treatments for schizophrenia. RSC Med Chem 2021;12:1459-75. [PMID: 34671731 DOI: 10.1039/d1md00096a] [Reference Citation Analysis]
18 González-López MDC, García-Ramón MJ, Nievas-Soriano BJ, Parrón-Carreño T. Assessment of the Risk of Antipsychotics in Patients with Dementia in Actual Clinical Practice in Primary Health Care. Pharmaceuticals (Basel) 2021;14:997. [PMID: 34681225 DOI: 10.3390/ph14100997] [Reference Citation Analysis]
19 Magierski R, Sobow T, Schwertner E, Religa D. Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: State of the Art and Future Progress. Front Pharmacol 2020;11:1168. [PMID: 32848775 DOI: 10.3389/fphar.2020.01168] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
20 Nakamura ZM, Deal AM, Rosenstein DL, Quillen LJ, Chien SA, Wood WA, Shea TC, Park EM. Design of a randomized placebo controlled trial of high dose intravenous thiamine for the prevention of delirium in allogeneic hematopoietic stem cell transplantation. Contemp Clin Trials 2020;95:106076. [PMID: 32619524 DOI: 10.1016/j.cct.2020.106076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Lee S, Angel C, Han JH. Succinct Approach to Delirium in the Emergency Department. Curr Emerg Hosp Med Rep 2021;:1-8. [PMID: 33758677 DOI: 10.1007/s40138-021-00226-9] [Reference Citation Analysis]
22 Crystal S, Jarrín OF, Rosenthal M, Hermida R, Angell B. National Partnership to Improve Dementia Care in Nursing Homes Campaign: State and Facility Strategies, Impact, and Antipsychotic Reduction Outcomes. Innov Aging 2020;4:igaa018. [PMID: 32699827 DOI: 10.1093/geroni/igaa018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Khalil H, Hoppe D, Ameen N. Characteristics of voluntary reporting of adverse drug events related to antipsychotics in Australia: 14-year analysis. Ther Adv Drug Saf 2021;12:20420986211012854. [PMID: 34104400 DOI: 10.1177/20420986211012854] [Reference Citation Analysis]
24 Navia RO, Constantine LA. Palliative care for patients with advanced dementia. Nursing 2022;52:19-26. [PMID: 35196277 DOI: 10.1097/01.NURSE.0000820024.83629.ee] [Reference Citation Analysis]
25 Robins LM, Lee DA, Bell JS, Srikanth V, Möhler R, Hill KD, Haines TP. Definition and Measurement of Physical and Chemical Restraint in Long-Term Care: A Systematic Review. Int J Environ Res Public Health 2021;18:3639. [PMID: 33807413 DOI: 10.3390/ijerph18073639] [Reference Citation Analysis]
26 Du Y, Wolf IK, Busch MA, Knopf H. Associations between the use of specific psychotropic drugs and all-cause mortality among older adults in Germany: Results of the mortality follow-up of the German National Health Interview and Examination Survey 1998. PLoS One 2019;14:e0210695. [PMID: 30640945 DOI: 10.1371/journal.pone.0210695] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
27 Seeman MV. Women who suffer from schizophrenia: Critical issues. World J Psychiatr 2018; 8(5): 125-136 [PMID: 30425943 DOI: 10.5498/wjp.v8.i5.125] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
28 Walsh KA, Byrne S, McSharry J, Browne J, Irving K, Hurley E, Rochford-Brennan H, Geoghegan C, Presseau J, Timmons S. Developing a complex intervention targeting antipsychotic prescribing to nursing home residents with dementia. HRB Open Res 2021;4:23. [PMID: 34136749 DOI: 10.12688/hrbopenres.13228.1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Heilman KM, Nadeau SE. Emotional and Neuropsychiatric Disorders Associated with Alzheimer's Disease. Neurotherapeutics 2022. [PMID: 35013934 DOI: 10.1007/s13311-021-01172-w] [Reference Citation Analysis]
30 Elvir-Lazo OL, White PF, Cruz Eng H, Yumul F, Chua R, Yumul R. Impact of chronic medications in the perioperative period: mechanisms of action and adverse drug effects (Part I). Postgrad Med 2021;:1-14. [PMID: 34551662 DOI: 10.1080/00325481.2021.1982297] [Reference Citation Analysis]
31 Luthra AS, Gao RL, Remers S, Carducci P, Sue J. Evidence-Informed Approach to De-Prescribing of Atypical Antipsychotics (AAP) in the Management of Behavioral Expressions (BE) in Advanced Neurocognitive Disorders (NCD): Results of a Retrospective Study. Geriatrics 2022;7:14. [DOI: 10.3390/geriatrics7010014] [Reference Citation Analysis]